Search

Search Results

• GLP-1 Agonists and Dual Agonists in Obesity Treatment: Benefits, Risks, and Clinical Challenges in Geriatric Patients

  Lidia Wydeheft , Justyna Jusiak , Paulina Halik, Paulina Malon, Kornelia Kędziora-Kornatowska

  67673

  2026-01-10
• Insights into the Efficacy of GLP-1 Agonists and Dual Agonists: Semaglutide and Tirzepatide in Obesity and Type 2 Diabetes

  Laura Opalska, Adrianna Muciek, Martyna Mocarska, Anna Orłowska, Katarzyna Strakowska, Anna Maryńczak, Jan Mencel, Nicole Nitschke

  56425

  2024-12-16
• Glucagon-like peptide-1 receptor agonists and derivatives in the treatment of obesity - review

  Michal Rabenda, Adam Słomczyński, Piotr Zatyka, Agata Pawłowska, Dominika Opala, Dobromiła Osuch, Piotr Janik

  53995

  2024-08-23
• The Impact of GLP-1 Receptor Agonists on Body Composition and Musculoskeletal Integrity: A Review of Mechanisms, Protective Strategies, and Clinical Perspectives

  Szymon Domagała, Zuzanna Wiater, Aleksandra Włodarczyk, Karolina Brankowska, Marta Jakubowska, Michał Olejnik, Paulina Tymińska, Piotr Artur Górka, Julia Frączek, Witold Kądziołka

  69771

  2026-03-24
• Neuroprotective Mechanisms of GLP‑1 Pathway Activation in Parkinson’s Disease - Foundations For Future Disease‑Modifying Strategies

  Gabriela Chmiel, Patryk Bachurski, Paweł Kalinowski, Maja Międlar, Martyna Muda, Szymon Pacek, Elisabetta Pierzga, Karol Paweł Wiśniewski, Paweł Witkowski, Bartosz Zarański

  68253

  2026-02-01
• From GLP-1 Agonism to Triple-Receptor Therapy. Narrative Review of Semaglutide, Tirzepatide, and Retatrutide in Obesity Management.

  Jerzy Darmoń, Joanna Makowska, Karolina Domańska, Natalia Piegza, Anna Sieczka, Maria Windyga, Krzysztof Paweł Darmoń, Aleksandra Papuga, Makary Hejduk

  70772

  2026-04-21
• Glucagon-Like Peptide-1 Receptor Agonists in Obesity Management: Mechanisms, Efficacy, and Safety

  Michał Stasiak, Wiktor Żyro, Karolina Woźniak, Katarzyna Żyro, Franciszek Glapiński, Adam Woźniak

  60634

  2025-06-17
• Drugs Used in the Treatment of Obesity – A Systematic Review

  Olga Plinta, Filip Bednarek, Alicja Hojda, Izabela Małajewicz, Natalia Nawrocka, Karolina Oskroba, Małgorzata Pietrzyk, Hanna Rodak, Dawid Stępień

  67976

  2026-02-05
• Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Evolving Insights into Pathogenesis, Progression, and Personalized Treatment Approaches

  Paweł Kukiełka, Katarzyna Moliszewska , Joanna Kośka , Kacper Dywan , Michał Błaszkiewicz , Julia Mazurek , Julia Załęcka , Alicja Nowik , Martyna Musiorska , Gabriela Łocik

  62408

  2025-07-14
• Beyond Glycemic Control: The Expanding Role of GLP-1 Analogues in Type 2 Diabetes and Metabolic Health

  Michał Mazur, Dorota Waz, Jakub Szarłowicz, Zofia Goliszek, Karolina Łucja Sobek, Wiktoria Tabin-Barczak, Aldona Sokołowska, Klaudia Fikas, Kamil Chwaliszewski, Sebastian Samuła

  56722

  2024-12-20
• Tirzepatide - role in obesity, health and physical wellness. Information overview

  Anna Hanslik, Magdalena Mendak, Agata Białek, Agnieszka Walczak, Adrian Hovagimyan, Monika Olszanecka, Tomasz Olszanecki

  58191

  2025-02-13
• Tirzepatide - a new drug with great potential in controlling glycemia and body weight

  Magdalena Stabrawa , Filip Prusinowski , Maria Teresa Sarata , Aleksandra Kutaj, Tatyana Savitskaya, Ignacy Hatala, Kiryl Savitski

  69364

  2026-03-06